BiotechTube
Home/BrYet/Dawn Cox
DC

Dawn Cox

Chief Administrative Officer

BrYet

Therapeutic Areas

Oncology

BrYet Pipeline

DrugIndicationPhase
ML-016 (iNPG-pDox)Lung and Liver MetastasesPhase 1/2

Leadership Team at BrYet

MF
Mauro Ferrari, PhD
President, CEO, and Board Chair
BS
Brian Sapp
Chief Technology Officer
MW
Matt Wagener
Director of Clinical Operations
LP
Lorenzo Pradella
Chief Executive Officer, BrYet Europe
GB
Gary Brewster, MBA
Senior Strategic Advisor to the CEO
CC
Christopher Cano, MBA
Director of Business Development
View full BrYet profile